公开(公告)号：EP4331671A1

公开(公告)日：2024-03-06

申请号：EP22795407.0

申请日：2022-03-25

Applicant: Suntory Holdings Limited

Inventor： KATSUBE, Makoto ,  WATANABE, Hiroshi ,  MURAYAMA, Norihito

IPC: A61P25/22 ,  A61P43/00 ,  A61K36/07 ,  A61K31/4172 ,  A23L33/175

Abstract: The present invention aims to provide an anxiolytic composition for humans and a method of preventing or reducing an anxiety symptom. The present invention relates to an anxiolytic composition for humans, containing L-ergothioneine or a salt thereof as an active ingredient.

公开(公告)号：EP3681479B1

公开(公告)日：2024-01-31

申请号：EP18856604.6

申请日：2018-09-14

Inventor： BEAL, Ryan ,  BRUNNER, Seth ,  SAND, Bruce ,  BYERS, Jeff ,  MISELL, Lisa ,  FITZSIMMONS, Nathan ,  SAND, Brandon ,  MARTINEZ, Kilmar ,  GONZALES, Luke

IPC: A61K9/107 ,  A61K9/70 ,  A61P35/04 ,  A61K9/00 ,  A61K9/06 ,  A61K31/133 ,  A61K31/198 ,  A61K31/4172 ,  A61K31/661 ,  A61K31/685 ,  A61K31/704 ,  A61K33/00 ,  A61K33/30 ,  A61K33/42 ,  A61K39/395 ,  A61K39/00 ,  A61K47/02 ,  A61K47/10 ,  C07K16/28 ,  A61K31/045

公开(公告)号：EP4291182A1

公开(公告)日：2023-12-20

申请号：EP22711712.4

申请日：2022-02-15

Applicant: Conagen Inc.

Inventor： HAN, Jixiang ,  CLARKSON, Sonya ,  NUNN, David

IPC: A61K31/4172 ,  C12N1/20 ,  C12N9/02 ,  C12N9/88 ,  C12P13/04

公开(公告)号：EP4182026A1

公开(公告)日：2023-05-24

申请号：EP21843338.1

申请日：2021-07-19

Applicant: India Globalization Capital, Inc.

Inventor： MUKUNDA, Ramachandra ,  RAO, Jagadeesh Sridhara

IPC: A61P29/00 ,  A61K31/352 ,  A61K36/886 ,  A61K36/534 ,  A61K36/67 ,  A61K31/4172

公开(公告)号：EP4138811A1

公开(公告)日：2023-03-01

申请号：EP21792983.5

申请日：2021-04-26

Applicant: Radiomedix Inc.

Inventor： DELPASSAND, Ebrahim S. ,  TWOROWSKA, Izabela

IPC: A61K31/195 ,  A61K31/198 ,  A61K31/4172

公开(公告)号：EP4129270A1

公开(公告)日：2023-02-08

申请号：EP22178328.5

申请日：2016-09-27

Applicant: APR APPLIED PHARMA RESEARCH S.A.

Inventor： REINER, Alberto ,  REINER, Giorgio

IPC: A61K9/00 ,  A61K45/06 ,  A61K9/16 ,  A61K9/50 ,  A61K31/198 ,  A61K31/401 ,  A61K31/405 ,  A61K31/4172 ,  A23L33/175 ,  A61K9/20 ,  A21D2/24 ,  A23L33/16 ,  A61P3/00 ,  A23L33/15

Abstract: Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.

公开(公告)号：EP4082615A1

公开(公告)日：2022-11-02

申请号：EP20905606.8

申请日：2020-12-25

Applicant: National Center for Child Health and Development

Inventor： MIYADO, Kenji ,  MIYAMOTO, Yoshitaka

IPC: A61P15/08 ,  A61P43/00 ,  C12N5/073 ,  C12N5/075 ,  C12N5/076 ,  C12N1/00 ,  C12N1/04 ,  A61K31/4172

Abstract: Provided is a novel means of inhibiting fertilized egg fragmentation. The present invention provides an inhibitor of fertilized egg fragmentation, said inhibitor comprising selenoneine or ergothioneine, a tautomer or dimer thereof, or a pharmaceutically acceptable salt of the same as an active agent.

公开(公告)号：EP3749339B1

公开(公告)日：2022-08-03

申请号：EP19714777.0

申请日：2019-01-30

Inventor： ELLEGÅRD, Katrine, Hvid ,  BAGGER, Christian, Lorentz ,  MYHREN, Finn ,  WIKLUND, Erik, Digman

IPC: A61K35/612 ,  A61K38/01 ,  A23K10/22 ,  A23K20/147 ,  A23J3/34 ,  A23L33/18 ,  A61K31/131 ,  A61K31/198 ,  A61K31/401 ,  A61K31/405 ,  A61K33/00 ,  A61K33/06 ,  A61K33/16 ,  A23L33/10 ,  A61K35/60 ,  A61K31/04 ,  A61K31/4172

公开(公告)号：EP3351554B1

公开(公告)日：2021-06-09

申请号：EP18157990.5

申请日：2013-06-18

Inventor： FASANO, Francesca Romana ,  BUDELLI, Andrea Luigi

IPC: C07K14/335 ,  A61K31/401 ,  A23L33/135 ,  A61K35/747 ,  A61K31/708 ,  A61K31/4172 ,  A61K31/045 ,  A61K31/19 ,  A61K31/198 ,  A61K38/16 ,  A23L33/00 ,  A61P1/00 ,  A61P19/00 ,  A61P25/00 ,  A61P29/00 ,  A61P29/02 ,  A61P37/00

公开(公告)号：EP3816278A1

公开(公告)日：2021-05-05

申请号：EP19826692.6

申请日：2019-06-11

Applicant: Nagase & Co., Ltd.

Inventor： KOSAKA, Kunio

IPC: C12N5/077 ,  A23L33/175 ,  A61K31/4172 ,  A61P21/00 ,  C12N1/00

Abstract: The present invention provides: a culture medium and a culture medium additive which are for myogenic differentiation promotion and which contain ergothioneine, ascorbic acid 2-glucoside, ascorbic acid, or a combination thereof; a kit; and a pharmaceutical composition and food and drink for myogenic differentiation promotion.